Artelo Biosciences Inc. (ARTLW)
NASDAQ: ARTLW
· Real-Time Price · USD
0.01
0.00 (78.57%)
At close: Jun 17, 2024, 10:00 PM
Artelo Biosciences Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -10.17M | -9.95M | -10.63M | -10.29M | -9.36M | -8.86M | -8.64M | -8.56M | -7.44M | -6.58M | -5.28M |
Interest Income | n/a | n/a | 1K | 2K | 4K | 4.54K | 4.18K | 3.43K | 1.43K | 889.00 | 253.00 |
Pretax Income | -9.55M | -9.44M | -10.29M | -10.08M | -9.29M | -8.85M | -8.65M | -8.55M | -7.44M | -6.58M | -5.28M |
Net Income | -9.29M | -9.1M | -9.93M | -9.87M | -9.22M | -8.85M | -8.67M | -8.55M | -7.44M | -6.58M | -5.28M |
Selling & General & Admin | 4.87M | 5.16M | 5.54M | 5.96M | 5.49M | 5.45M | 5.33M | 5.05M | 4.62M | 4.1M | 3.49M |
Research & Development | 5.3M | 4.79M | 5.09M | 4.32M | 3.87M | 3.41M | 3.3M | 3.5M | 2.82M | 2.48M | 1.8M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 62.00 | 629.00 | 843.00 | 1.05K |
Operating Expenses | 10M | 9.95M | 10.63M | 10.29M | 9.36M | 8.86M | 8.64M | 8.56M | 7.44M | 6.58M | 5.28M |
Interest Expense | n/a | 5K | 5K | 24K | 24K | 19K | 19K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10M | 9.95M | 10.63M | 10.29M | 9.36M | 8.86M | 8.64M | 8.56M | 7.44M | 6.58M | 5.28M |
Income Tax Expense | -99K | -333K | -355K | -212K | -76K | -7.22K | 13.15K | -7.43K | -4K | -3.99K | -2.57K |
Shares Outstanding (Basic) | 2.95M | 2.86M | 2.86M | 2.83M | 2.85M | 2.83M | 2.82M | 2.03M | 30.44M | 1.54M | 1.13M |
Shares Outstanding (Diluted) | 2.95M | 2.86M | 2.86M | 2.83M | 2.85M | 2.83M | 2.82M | 2.03M | 30.44M | 1.54M | 1.13M |
EPS (Basic) | -3.24 | -3.2 | -3.5 | -3.48 | -3.61 | -2.88 | -3.48 | -4.43 | -5.28 | -5.32 | -7.98 |
EPS (Diluted) | -3.24 | -3.2 | -3.5 | -3.48 | -3.61 | -2.88 | -3.48 | -4.43 | -5.28 | -5.32 | -7.98 |
EBITDA | -7.7M | -10.26M | -10.78M | -10.29M | -9.37M | -8.86M | -8.62M | -8.56M | -7.44M | -6.58M | -5.28M |
EBIT | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 2.23M | -353.92K | -189.92K | -45.92K | 30.08K | 3.23K | 24.29K | 4.35K | 408.00 | 311.00 | 374.00 |